Journal article
The Prevention of cerebrovascular and cardiovascular Events of ischemic origin with teRutroban in patients with a history oF ischemic strOke or tRansient ischeMic attack (PERFORM) study: baseline characteristics of the population.
- Abstract:
-
BACKGROUND: The Prevention of cerebrovascular and cardiovascular Events of ischemic origin with teRutroban in patients with a history oF ischemic strOke or tRansient ischeMic attack (PERFORM) study is an international double-blind, randomized controlled trial designed to investigate the superiority of the specific TP receptor antagonist terutroban (30 mg/day) over aspirin (100 mg/day), in reducing cerebrovascular and cardiovascular events in patients with a recent history of ischemic stroke ...
Expand abstract
- Publication status:
- Published
Actions
Authors
Bibliographic Details
- Journal:
- Cerebrovascular diseases (Basel, Switzerland)
- Volume:
- 27
- Issue:
- 6
- Pages:
- 608-613
- Publication date:
- 2009-01-01
- DOI:
- EISSN:
-
1421-9786
- ISSN:
-
1015-9770
- Source identifiers:
-
119560
Item Description
- Language:
- English
- Keywords:
- Pubs id:
-
pubs:119560
- UUID:
-
uuid:ede96413-a22a-48b2-a3b9-e41dc8347452
- Local pid:
- pubs:119560
- Deposit date:
- 2012-12-19
Terms of use
- Copyright date:
- 2009
If you are the owner of this record, you can report an update to it here: Report update to this record